MT1013 Injection for the Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease

Clinical trial NCT06690242 · COMPLETED

Trial details

NCT number: NCT06690242
Sponsor: Shaanxi Micot Pharmaceutical Technology Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis

Start date: 2024-11-04
Primary completion: 2025-08-30
Enrollment: 115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.